Vitreous Fibronectin and Fibrinogen Expression Increased in Eyes With Proliferative Diabetic Retinopathy After Intravitreal Anti-VEGF Therapy
Author(s) -
Qiaoling Wei,
Ting Zhang,
Rui Jiang,
Qing Chang,
Yanqiong Zhang,
Xin Huang,
Xing Gao,
Hong Jin,
Gezhi Xu
Publication year - 2017
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.17-22345
Subject(s) - vitrectomy , fibronectin , medicine , fibrinogen , diabetic retinopathy , fibrin , vascular endothelial growth factor , diabetes mellitus , pars plana , retinopathy , ophthalmology , endocrinology , visual acuity , immunology , vegf receptors , chemistry , biochemistry , extracellular matrix
To evaluate vitreous humor (VH) protein expression profiles in patients with proliferative diabetic retinopathy (PDR), with and without intravitreal injection (IVI) of anti-vascular endothelial growth factor (anti-VEGF) before vitrectomy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom